Insight Resource Library Tap into Gubra’s vast production of publications, webinars, videos and posters to get the latest knowledge and insights within our focus areas: obesity, diabetes, MASH, CKD, IPF and IBD. Filtered (20) Filters Reset all × GIPRA × Gut morphometry × Parkinson's disease × Search × Resource type Data presentation (0) Poster (4) Publication (14) 3D imaging video (0) Webinar (2) Category × Disease model (212) Cardiovascular disease (10) AngII mouse (1) DIO-ApoE-KO mouse (1) DIO-LDLR-KO mouse (4) DIO-PCK9-AAV mouse (1) Isoprenaline-induced cardiomyopathy (1) Cholangiopathy (1) Bile duct ligation (BDL) mouse (1) Mdr2-KO mouse (1) CNS disease (39) Alzheimer's disease models (9) CNS activation (12) Drug distribution (6) Gene expression (1) Gene therapy (1) Parkinson's disease models (6) Diabetes (33) db/db mouse (17) Non-obese diabetic (NOD) mouse (4) ZDF rat (10) Inflammatory bowel disease (2) Acute DSS-IBD mouse (0) Chronic DSS-IBD mouse (2) Idiopathic pulmonary fibrosis (5) BLEO-IPF mouse (3) Chronic BLEO-IPF mouse (1) HFD-BLEO-IPF mouse (0) Kidney disease (31) Acute kidney injury (4) Bilateral ischemia reperfusion injury (bIRI) mouse (1) Unilateral ischemia reperfusion injury (uIRI) mouse (3) Chronic kidney disease (16) Anti-GBM glomerulonephritis mouse (1) Adenine diet-induced (ADI) nephropathy mouse (5) Polycystic kidney disease (PCK) rat (1) Unilateral ureteral obstruction (UUO) mouse (4) 5/6 nephrectomy (Nx) rat (2) Diabetic kidney disease (17) db/db-UNx mouse (1) ReninAAV UNx db/db mouse (11) ZSF-1 rat (0) Knock-out mouse models (8) Metabolic dysfunction-associated steatohepatitis (72) GAN DIO-MASH mouse (28) GAN DIO-MASH-HCC mouse (7) GAN ob/ob-MASH mouse (4) CDAA-HFD mouse (8) CDAA-HFD rat (9) AMLN DIO-MASH mouse (16) AMLN ob/ob-MASH mouse (12) Obesity (51) Bariatric surgery (10) DIO mouse (22) DIO rat (14) ob/ob mouse (8) Therapeutic Area (231) Alzheimer's disease (13) Alcoholic steatohepatitis (2) Cardiovascular disease (9) Chronic kidney disease (26) Cholangiopathy (1) Diabetes (55) Diabetic cardiomyopathy (2) Diabetic kidney disease (18) Hepatocellular carcinoma (5) Idiopathic pulmonary fibrosis (5) Inflammatory bowel disease (2) Metabolic dysfunction-associated steatohepatitis (80) Obesity (80) Parkinson's disease (8) Target (143) Alpha-synuclein (1) Autotaxin (1) Beta amyloid (4) Acetyl-CoA carboxylase (2) Amylin receptor (4) Angiotensin converting enzyme (ACE) (4) AMPK (1) ASBT (2) CB1 receptor (5) CCK receptor (4) D2 receptor (3) DPP-IV (2) Fatty acid synthase (1) FGF receptor-1 (3) FXR (12) GCC receptor (1) GFRAL (1) Ghrelin receptor (3) GIP receptor (4) GLP-1 receptor (71) GLP-2 receptor (5) Glucagon receptor (5) GPR119 (0) GPR120 (1) G-protein coupled receptor 10 (GPR10) (1) HSD17b13 (1) 5-HT2C receptor (3) IL-1beta receptor (1) Insulin receptor (2) mARC1 (1) MC4 receptor (4) Monoamine transporter (2) Leptin receptor (1) Neuropeptide FF receptor type 2 (1) Neurotensin receptor (1) Nicotinic acetylcholine receptor (1) NPY receptor (2) NMU receptor (2) PCSK9 (1) PICK1 (1) PPAR (22) PSD-95 (1) Renin–angiotensin system (3) Secretin receptor (1) SGLT-2 (5) TAAR1 (1) TGF-beta (5) TGR5 (2) THR-ß receptor (5) Y2 receptor (3) Compound (140) Aducanumab biosimilar (4) Adeno-associated virus (AAV)-mediated gene therapy (1) A3907 (2) Adrenomedullin (2) Alk5 inhibitor (4) ALT-801 (1) Amylin (3) Amylin receptor agonist (1) BLD-0409 (1) Bromocriptine (2) CHS-131 (1) Captopril (1) Cilofexor (1) Cotadutide (1) DA-1241 (1) Dapagliflozin (2) Dietary intervention (4) Exenatide (9) Elafibranor (9) Empagliflozin (4) Exendin-4 analogues (3) FGF21 (3) Firsocostat (2) GDF15 analogues (1) Ghrelin (1) GIP receptor agonist (1) GIPRA (1) GIP receptor antagonist (1) Glibenclamide (1) GLP-1 (5) GLP-1 receptor agonist (5) GLP-2 (1) Glucagon receptor agonist (1) Glucose-dependent insulinotropic polypeptide (GIP) (1) Guanylin (1) GUB06-046 (1) GUB08-248 (1) GUB09-123 (1) GUB09-145 (2) GUB08251 (1) GUB021794 (1) GUBamy (1) GS-834356 (1) HSD17b13 inhibitor (1) Icosabutate (1) ID166 (0) Insulin (1) INT-767 (4) INT-787 (0) Lanifibranor (9) LEAP-2 (2) Leptin (1) Linagliptin (5) Liraglutide (30) Lisinopril (4) Lorcaserin (3) MEDI0382 (1) mPD95 (1) Neuromedin U (2) Neurotensin (1) Neurturin (1) Nicotine (1) Obeticholic acid (10) Oxyntomodulin (1) PYY3-36 (4) Prolactin-releasing peptide (1) Resmetirom (6) Rimonabant (4) Rosiglitazone (2) S961 (1) Salmon calcitonin (1) SEFA-1024 (1) Seladelpar (2) Semaglutide (28) SER140 (1) Setmelanotide (3) Sibutramine (4) TAAR1 agonists (1) Taspoglutide (1) Teduglutide (2) TVB-3664 (1) UCCB01-147 (1) Uroguanylin (1) Y2 receptor agonist (1) ZP3022 (3) Method/Endpoint (253) 3D imaging (55) Adeno-associated virus (AAV)-mediated gene delivery (14) Atherosclerotic plaques (3) Beta-cell mass (12) Blood pressure (1) Body composition (11) Body weight (115) Blood biochemistry (77) Bariatric surgery (12) Bioinformatics (101) c-Fos activation (19) Clinical trial (2) Conditioned taste aversion test (1) Drug discovery (25) Drug distribution (11) Energy expenditure monitoring (4) Echocardiography (ECG) (3) Flow cytometry (1) Gut biopsy (6) Glomerular filtration rate (GFR) (7) Gastric emptying (3) Gut morphometry (11) Glucose-stimulated insulin secretion (GSIS) (1) Histopathology score (71) Heart morphometry (4) Intraperitoneal glucose tolerance test (IPGTT) (7) Image analysis (138) Immunohistochemistry (IHC) (136) In situ hybridization (ISH) (14) Insulin tolerance test (ITT) (2) Kidney biopsy (2) Kidney morphometry (22) Lung functional test (3) Light sheet fluorescence microscopy (LSFM) (58) Liver biopsy (64) Liver morphometry (62) Lung biochemistry (2) Laser-capture microdissection (LCM) (9) Magnetic resonance imaging (MRI) (2) Microbiomics (5) Micro-computed tomography (micro-CT) (1) Neurobehavior (6) Next-generation sequencing (44) Nephrectomy (14) Oral glucose tolerance test (OGTT) (20) Pancreatectomy (1) Peptide chemistry (14) Pharmacokinetics (9) Proteomics (1) qPCR (1) Real-time food intake/activity analysis (32) Receptor binding (3) Roux-en-Y gastric bypass (RYGB) (8) RNA sequencing (79) Single-cell RNA sequencing (3) Single-nucleus RNA sequencing (6) siRNA (1) StreaMLine (1) Surgery (12) Spirometry (3) Stereology (29) Stereotaxic injection (2) Ultrasound imaging (1) Urine biochemistry (12) Vasculature (2) Vertical sleeve gastrectomy (1) Western Blotting (1) Whole-body plethysmography (2) Whole-brain in situ hybridization (3) Species (207) Hamster (1) Human (28) Mouse (166) Minipig (2) Non-human primate (3) Pig (3) Rat (32) Show (20) Cancel Sort result Default sorting By title: alphabetical By title: reverse By date: oldest first By date: newest first Reset all × GIPRA × Gut morphometry × Parkinson's disease × 20 resource library items found PosterHistological disease progression and ALK5i therapeutic efficacy in a chronic DSS-induced mouse model of IBD with intestinal fibrosis PosterWhole-brain 3D mapping and quantification of pathological α-Synuclein aggregate spreading and toxicity in a mouse model of early-stage Parkinson’s disease WebinarWhole organ staining and 3D light sheet imaging for pharmacological research PublicationQuantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson’s disease PosterHistopathological characterization of a chronic DSS-induced mouse model of IBD with intestinal fibrosis PublicationGIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior WebinarWhole brain imaging using light sheet microscopy PosterQuantitative whole-brain 3D imaging of dopaminergic cell architecture in the mouse MPTP model of Parkinson’s disease PublicationWhole-brain 3D imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases PublicationMastiha (Pistacia Lentiscus) improves gut microbiota diversity, hepatic steatosis and disease activity in a biopsy-confirmed mouse model of advanced non-alcoholic steatohepatitis and fibrosis PublicationInvestigating intestinal glucagon after Roux-en-Y gastric bypass surgery PublicationNovel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice PublicationApplication of the physical disector principle for quantification of dopaminergic neuronal loss in a rat 6-hydroxydopamine nigral lesion model of Parkinson’s disease PublicationEnteroendocrine K and L cells in healthy and type 2 diabetic individuals PublicationThe endogenous preproglucagon system is not essential for gut growth homeostasis in mice PublicationCharacterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson’s disease PublicationRapid gut growth but persistent delay in digestive function in the postnatal period of preterm pigs PublicationPost-surgical effects of Roux-en-Y gastric bypass on glucose homeostasis, intestinal morphology and L-cells in obese Göttingen minipigs PublicationHypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats PublicationNovel insight into the distribution of L-cells in the rat intestinal tract For further information Contact us Gubra Hørsholm Kongevej 11B 2970 Hørsholm Denmark +45 3152 2650